Depression News

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics.

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as monotherapy for adults with treatment-resistant depression, Johnson & Johnson announced in a press release.

Women firefighters reporting a history of clinically diagnosed anxiety or PTSD were more likely to have lower anti-Müllerian hormone levels, potentially impacting reproductive health, researchers reported in the Journal of Women’s Health.

Presence of a protein-binding biomarker in a small cohort of adults with depression may be an indicator that suicidal ideation increases because of elevated stress, according to research from JAMA Psychiatry.

Mothers taking antidepressants or anti-inflammatory medications had lower protein and fat levels in breastmilk, which may cause health risks for infants, but researchers noted that more studies are needed to confirm the findings.

In a newly published paper, the American Academy of Neurology promoted 12 key concepts for patients and providers to successfully promote and maintain brain health.

The presence of Type D personality among patients with CAD or their spouses was associated with elevated risk for cardiac events, according to a study published in the European Journal of Preventive Cardiology.

Exposure to higher ambient temperatures during pregnancy and the postpartum period was associated with increased risk for postpartum depression, highlighting the potential impact of climate change on maternal mental health, data show.

At the Alzheimer's Association International Conference, the Lancet Commission unveiled two new modifiable risk factors for dementia: high cholesterol and vision loss.